Former partner David Lynn is rejoining Morrison & Foerster’s Corporate Department and Corporate Finance group and will be based in the Washington DC office. Lynn, a specialist in securities, corporate governance and public company counselling, previously served as the Chief Counsel of the US Securities and Exchange Commission’s Division of Corporation Finance. At the SEC, Lynn led the SEC’s efforts to implement and interpret the rules adopted by the SEC following passage of the Sarbanes-Oxley Act of 2002. Lynn also led the SEC’s rulemaking team that drafted amendments to the SEC’s executive compensation and related party disclosure rules in 2006. 

Rabobank, a global food and agribusiness bank, has appointed Gregg Fatzinger and Dean Asofsky as co-heads of its Wholesale Banking Mergers & Acquisitions (M&A) business in North America. The appointments reflect Rabobank’s growing M&A advisory presence in North America and globally, including recent deals such as Marfrig’s pending USD969 million acquisition of a 51 per cent controlling interest in National Beef and Fresh Del Monte’s USD361 million acquisition of Mann Packing. Asofsky and Fatzinger are based in New York and will lead a North American team that falls under Global Head of Mergers & Acquisitions Don Meltzer, and that is

Social and Sustainable Capital (SASC), an UK fund manager and social enterprise, has strengthened its team with the appointment of Amelia Sussman in the new role of Head of Operations. She is one of four new recruits to SASC this year, which has seen the team grow to 10 people.   Sussman previously worked at Impetus – The Private Equity Foundation, where she was an Investment Director for 11 years, working closely with a portfolio of charities and the private equity community.  Before joining Impetus PEF, she was COO at Common Purpose.    Commenting on her new role, Sussman says,

BakerHostetler has appointed Michael Moyer as a partner in the firm’s Seattle office, where he will work on clients’ corporate finance, project finance and other complex transactional needs.   Moyer comes to BakerHostetler from Cairncross & Hempelmann, PS. He is the first partner in the firm’s Business Group to be based in the Seattle office.   Moyer has represented a broad array of companies during his more than two decades as a corporate finance attorney. Though he continues to represent various types of clients, Moyer focuses his practice primarily on serving sustainable industry, life science and other technology companies. He

Idinvest Partners, an investor in SMEs across Europe, has appointed Guillaume Santamaria as Investment Director for the firm’s Growth Capital team, which held its first closing at EUR250 million in November 2016. In this role, Guillaume Santamaria me will be involved in sourcing, analysing and executing investments for the Growth Capital team, both in France and across Europe.   Before joining Idinvest Partners, Santamaria originated and executed over 10 operations on both fundraising and M&A with Apparius Corporate Finance, an independent M&A firm specialised in TMT where he started the digital health practice. Prior to this, Santamaria was part of Quilvest Group,

Law firm Paul Hastings has added M&A partner Roger Barron to the firm’s team in London. Barron has been a partner at Linklaters for more than 17 years.   “Roger has an outstanding market presence, with considerable experience and a formidable track record with a number of blue-chip clients,” says Seth Zachary, chair of Paul Hastings. “This significant appointment underlines our focus and commitment to accelerate the growth of our M&A practice in London, and enhance our offering to the firm’s global clients.”   “The London legal market is in a dynamic state and I believe that Paul Hastings is

Results Healthcare, a corporate advisory firm focused on public and private healthcare and life sciences companies, has appointed Jason Foss as Managing Director. Based in Atlanta, Georgia, Foss will work alongside colleagues in Results’ existing New York office to drive the growth of the firm’s operations in the world’s largest healthcare market, the USA.   With over 20 years’ experience, Foss is a highly knowledgeable healthcare investment banker having started his career at Morgan Stanley before moving to the United Kingdom to work at a variety of bulge bracket banks including UBS and Citi. In these roles Jason advised clients